genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2014
Antiparkinson drugs
News
Lasker 2014 Awards Honor Five Scientists Excelling in Basic and Applied Clinical Research
News
MJFF Supports Trial Evaluating Treatment for Levodopa-Induced Dyskinesia
News
Impax and GSK Report Positive Data from Third Phase III Study with Parkinson Disease Drug
Drug Discovery
Envoy Awarded MJFF Grant to Develop Oral Drug for Parkinson Disease
News
Adolor Awarded $0.3M by MJFF to Develop PD Drugs for Levodopa-Induced Dyskinesia
News
Pivotal Trial Shows Adding Safinamide to Levodopa Stabilizes Dyskinesia in PD for Two Years
News
Ipsen Acquires Santhera’s Parkinson Drug for €13M Up Front
News
Omeros Signs On Parkinson’s Institute for Preclinical Studies
1
2
Page 2 of 2
Scroll Up
Scroll Up
